PROHANCE MULTIPACK Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Prohance Multipack, and what generic alternatives are available?
Prohance Multipack is a drug marketed by Bracco and is included in one NDA.
The generic ingredient in PROHANCE MULTIPACK is gadoteridol. One supplier is listed for this compound. Additional details are available on the gadoteridol profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROHANCE MULTIPACK?
- What are the global sales for PROHANCE MULTIPACK?
- What is Average Wholesale Price for PROHANCE MULTIPACK?
Summary for PROHANCE MULTIPACK
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 34 |
Clinical Trials: | 9 |
Patent Applications: | 655 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROHANCE MULTIPACK at DailyMed |
![PROHANCE MULTIPACK drug patent expirations Drug patent expirations by year for PROHANCE MULTIPACK](/p/graph/s/t/PROHANCE_MULTIPACK-patent-expirations.png)
Recent Clinical Trials for PROHANCE MULTIPACK
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Alabama at Birmingham | Early Phase 1 |
University of Alabama at Birmingham | Phase 1 |
IQVIA (Sponsor) | Phase 4 |
Pharmacology for PROHANCE MULTIPACK
Drug Class | Paramagnetic Contrast Agent |
Mechanism of Action | Magnetic Resonance Contrast Activity |
US Patents and Regulatory Information for PROHANCE MULTIPACK
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bracco | PROHANCE MULTIPACK | gadoteridol | INJECTABLE;INJECTION | 021489-001 | Oct 9, 2003 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PROHANCE MULTIPACK
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bracco | PROHANCE MULTIPACK | gadoteridol | INJECTABLE;INJECTION | 021489-001 | Oct 9, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Bracco | PROHANCE MULTIPACK | gadoteridol | INJECTABLE;INJECTION | 021489-001 | Oct 9, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Bracco | PROHANCE MULTIPACK | gadoteridol | INJECTABLE;INJECTION | 021489-001 | Oct 9, 2003 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PROHANCE MULTIPACK
See the table below for patents covering PROHANCE MULTIPACK around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 1296715 | 1-(SUBSTITUANT)-1,4,7-TRIS(CARBOXYMETHYL)-1,4,7,10- TETRAAZACYCLODODECANE ET COMPOSES ANALOGUES (1-SUBSTITUTED-1,4,7-TRISCARBOXYMETHYL-1,4,7,10- TETRAAZACYCLODODECANE AND ANALOGS) | ⤷ Sign Up |
European Patent Office | 0232751 | 1-SUBSTITUTED-4,7,10-TRISCARBOXYMETHYL-1,4,7,10-TETRAAZACYCLODODECANE AND ANALOGS | ⤷ Sign Up |
Germany | 3772785 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |